Gold is 2025’s best performer. UBS sees more upside
In a challenging market environment, Modular Medical (TASE:BLWV) (MODD) stock has touched a 52-week low, with shares plummeting to $1.07. With a market capitalization of just $44.73 million and a beta of -3.72, the stock’s technical indicators from InvestingPro suggest oversold conditions. The medical device company, which has been navigating through a turbulent healthcare sector, has seen its stock price significantly retreat from higher levels over the past year. Investors have witnessed a stark 1-year change, with the stock value eroding by -37.71%, reflecting broader market trends and possibly company-specific headwinds. InvestingPro analysis reveals 8 additional key indicators that could help investors make informed decisions about MODD’s potential. This latest price level marks a concerning milestone for stakeholders and underscores the volatility that Modular Medical has faced in the market. According to InvestingPro’s Fair Value analysis, the stock appears to be trading below its estimated worth, suggesting potential opportunity amid the current market pessimism.
In other recent news, Modular Medical has announced a partnership with Nudge BG to develop an advanced Automated Insulin Delivery (AID) system. This collaboration aims to integrate Nudge BG’s adaptive technology with Modular Medical’s MODD1 insulin pump, creating a full closed-loop system that simplifies diabetes management. The new system is designed to automatically adjust insulin delivery based on continuous glucose monitoring data, reducing the need for manual mealtime insulin announcements. Lane Desborough, CEO of Nudge BG, highlighted the goal of automating mealtime insulin delivery to help users achieve their glycemic targets more effortlessly. Paul DiPerna, President and CTO of Modular Medical, stated that this partnership aligns with their mission to make diabetes management more accessible and less complex. The company is focusing on potential insulin pump users who find current systems too complicated or costly. The press release notes that while the collaboration has promising goals, there are risks and uncertainties involved in the project’s success and technology integration.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.